Consolidated Financial Results for the Year Ended March 31, 2012 (PDF: 168KB)
Sysmex Announces Changes from Financial Results and Year-End Dividend Forecasts for the Fiscal Year Ended March 31, 2012 (PDF: 60KB)
Announcement of Executive Change (PDF: 46KB)
Boosting Production Capacity to Strengthen the Protein Production Service Business- To Be Capable of Supplying More Than 1,000 Protein Types per Year -
Sysmex and Roche renew successful alliance in the hematology business－ Distributorship, sales and services agreement extends for another 10 years －
Domestic Reagent Production Facility News: Completion of New Ono Factory Wing－Supports approximately 1.5 times the previous production volume－
Sysmex to Be Special Sponsor of the Kobe Marathon 2012－We are pleased to continue our sponsorship of this exciting event－
Announcement of Organizational and Personnel Changes(PDF:92KB)
Announcement of Nakatani Award and Research Subsidy Recipients(PDF:60KB)
Summary of Consolidated Financial Results for the Nine months Ended December 31, 2011(PDF:144KB)
Sysmex to Begin Offering Laboratory Testing Service for Research Involving the Risk of Recurrence of Early-Stage Breast Cancer-Working to Achieve Personalized Medicine-
Sysmex Selected as One of 2012 Global 100's Most Sustainable Companies in the World
